Biomarker Associated With Poor Outcome In Aggressive Childhood Cancer

Results from a new study identify a biomarker that may be useful for predicting the outcome of treatment for neuroblastoma, the most common cancer in young children. The research also provides new information about the molecular signals that are involved in the progression of this often devastating pediatric cancer.
Full article >>